Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions

(a) Frequency of FGFR3-TACC3 fusion-positive cervical cancer in TCGA and Japanese datasets. Clinical information of FGFR3-TACC3 fusion-positive cervical cancer and two types of FGFR3-TACC3 fusion transcripts detected in the Japanese dataset are shown. b, c Scatter plot of FGFR3 and TACC3 mRNA expression in (b) TCGA dataset (n？=？306) or (c) Japanese dataset (n？=？103). FGFR3-TACC3 fusion-positive samples are highlighted in re